Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroendocrine differentiation in prostatic carcinoma: an update on recent developments.

P A di Sant'Agnese1

  • 1Department of Pathology, University of Rochester Medical Center, New York 14642, USA.

Annals of Oncology : Official Journal of the European Society for Medical Oncology
|January 5, 2002
PubMed
Summary

Neuroendocrine differentiation in prostate cancer is reviewed, focusing on experimental models and their impact on prognosis. A new hypothesis integrates this process into prostate cancer progression, especially in androgen-independent states.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mitochondrial DNA depletion in prostate epithelial cells promotes anoikis resistance and invasion through activation of PI3K/Akt2.

Cell death and differentiation·2008
Same author

Calcitonin and calcitonin gene-related peptide in the human prostate gland.

The Prostate·2000
Same author

Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma.

The Prostate. Supplement·1998
Same author

Neuroendocrine differentiation in prostatic carcinoma: an update.

The Prostate. Supplement·1998
Same author

Characterization of the cell-specific expression of parathyroid hormone-related protein in normal and neoplastic prostate tissue.

Urology·1998
Same author

Neuroendocrine cells of the prostate and neuroendocrine differentiation in prostatic carcinoma: a review of morphologic aspects.

Urology·1998

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Neuroendocrine differentiation (NED) is a critical process in prostate cancer (PC) progression.
  • Understanding NED mechanisms is vital for developing targeted therapies.
  • The role of NED in advanced, androgen-independent prostate cancer requires further elucidation.

Purpose of the Study:

  • To review recent advancements in neuroendocrine differentiation in prostate cancer.
  • To evaluate the fidelity of in vivo and in vitro experimental models of NED in PC.
  • To propose a hypothesis integrating NED into established models of PC evolution and progression.

Main Methods:

  • Comprehensive literature review of experimental models and clinical studies.
  • Analysis of in vivo and in vitro models for their relevance to human PC NED.

Related Experiment Videos

  • Synthesis of current knowledge to formulate a novel hypothesis.

    • Main Results:

    • Experimental models offer valuable insights but vary in their fidelity to human PC NED.
    • NED mechanisms significantly influence prostate cancer prognosis.
    • NED plays a crucial role in the progression of androgen-independent prostate cancer.

    Conclusions:

    • Experimental models are essential for studying prostate cancer neuroendocrine differentiation.
    • Neuroendocrine differentiation is a key driver of prostate cancer progression and impacts patient outcomes.
    • A novel hypothesis integrating NED into PC progression models provides a framework for future research, particularly in advanced disease.